DE
ELV icon

DV Equities’s Elevance Health ELV Stock Holding History

DV Equities’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$108K Buy
+309
New +$104K 0.02% 203

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

DV Equities's ELV Position: Q4 2025 in Review

DV Equities opened a new position in Elevance Health (ELV) in Q4 2025: 309 shares worth $108K. The stake represents 0.02% of the portfolio and ranks #203 among its holdings.

1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • DV Equities held 309 shares of Elevance Health worth $108K as of Q4 2025.
  • Elevance Health was a new DV Equities position in Q4 2025.
  • Elevance Health made up 0.02% of DV Equities's portfolio in Q4 2025, its #203 holding.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.